PropertyValue
?:definition
  • Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (usually urine) to determine in a short period of time (typically several minutes) the human complement factor H related protein that is secreted by neoplastic urinary bladder tumor cells (i.e., tumor markers). These assays (usually known as bladder tumor antigen [BTA] assays) are used to obtain information in tumor grade and clinical stage of urothelial carcinomas of the bladder.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3690764_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3690764_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all